ETIOLOGY OF SKIN LEISHMANIOSIS IN OF ENDEMIC REGIONS OF UZBEKISTAN ON THE EXAMPLE OF DZHIZAK REGION


Cite item

Full Text

Abstract

Taking into account the high prevalence of cutaneous leishmaniasis in Uzbekistan, as well as the tendency of increase in the incidence of this disease over the past 5 years, important and necessary is to determine the species composition of leishmania, as well as their vectors and natural reservoirs. According to the results of molecular-biological diagnostics, carried out in present study, in samples taken from ulcers of patients from Jizzakh region, which previously considered endemic for anthraponotic cutaneous leishmaniasis, was detected L.mayor, the causative agent of zoonotic cutaneous leishmaniasis.

About the authors

U. T Suvonkulov

L.M. Isaev Research Institute of Medical Parasitology, Ministry of Health of the Republic of Uzbekistan

Samarkand, 38 Isaev St., 140105

Olesya Djurabaevna Achilova

L.M. Isaev Research Institute of Medical Parasitology, Ministry of Health of the Republic of Uzbekistan

Email: aleska-9090@inbox.ru
scientific researcher of the Isaev Research Institute of Medical Parasitology, Samarkand, Uzbekistan Samarkand, 38 Isaev St., 140105

T. I Muratov

L.M. Isaev Research Institute of Medical Parasitology, Ministry of Health of the Republic of Uzbekistan

Samarkand, 38 Isaev St., 140105

Soon Yong Tai

Yonsei University

50 Yonsei-ro, Sinchon-dong, Seodaemun-gu, South Korea, 220003-220980 Seoul

Yi Myunhee

Yonsei University

50 Yonsei-ro, Sinchon-dong, Seodaemun-gu, South Korea, 220003-220980 Seoul

Yeong Kim Ju

Yonsei University

50 Yonsei-ro, Sinchon-dong, Seodaemun-gu, South Korea, 220003-220980 Seoul

V. S Turicin

St. Petersburg State Agrarian University, Ministry of Agriculture of Russia

Petersburg highway 2, 196601 St. Petersburg, Russia

References

  1. Desjeux P. Information on the epidemiology and control of the Leishmaniasis by country of territory. WHO, 1991, Switerland, Geneva.
  2. Clem, Angela A: Current Perspective on Leishmaniasis. Journal of Global Infectious Diseases. May2010, 2(2): 124-6.
  3. Chiodini P.L., Engback K., Hcuck C.C. Журнал «Медицина», «Основные методы лабораторной диагностики паразитарных болезней». Женева. ВОЗ. 1994.
  4. Дрынов И.Д., Сергиев В.П., Малышев Н.А. Профилактика массовых инфекционных и паразитарных болезней человека медикаментозными средствами. М., 1998.
  5. Артемьев М.М. Классификация москитов (Diptera, Psychodidae, Phlebotominae): Дис. д-ра биол. наук. М.; 1990.
  6. Понировский У.Н., Дарченкова Н.Н. Аридные экосистемы. 2005; 11(28): 39-50.
  7. Баранец М.С., Понировский Е.Н., Кадамов Д.С. Видовой состав и распространение москитов (Diptera, Psychodidae, Phlebotominae) Центральной Азии. Мед. паразитол. 2015; (4): 10-8.
  8. Moncaz, Aviad. Breeding Sites of Phlebotomussergenti, the Sand Fly Vector of Cutaneous Leishmaniasis in the Judean Desert. PLoS Neglected Tropical Diseases. Jul 2012; 6(7): е1725. doi: 10.1371/journal.pntd.0001725. Epub 2012 Jul 3.
  9. Ajaoud, Malika,Es-Sette, Nargys Phlebotomus sergenti in a Cutaneous Leishmaniasis Focus in Azilal Province (High Atlas, Morocco): Molecular Detection and Genotyping of Leishmania tropica, and Feeding Behavior. PLoS Neglected Tropical Diseases. Mar 2015; 9(3): 1-17.
  10. Долматова А.В. Об основных факторах, определяющих эпидемиологической значение отдельных видов москитов (Phlebotominae) в очагах лейшманиозов. Мед. паразитол. 1965; (3): 297-302.
  11. Кишкун А.А. Руководство по лабораторным методам исследования. М.; ГЕОТАР-Медиа, 2007.
  12. Hajjaran H; Vasigheh F., Mohebali M., Rezaei S., Mamishi S., Charedar S. Direct diagnosis of Leishmania species on serosity materials punctured from cutaneous leishmaniasis patients using PCR-RFLP. Journal Of Clinical Laboratory Analysis. 2011; 25(1): 20-4.
  13. Akkafa F; Dilmec F., Alpua Z. Identification of Leishmania parasites in clinical samples obtained from cutaneous leishmaniasis patients using PCR-RFLP technique in endemic region, Sanliurfa province, in Turkey. Parasitology Research. 2008 Aug; 103(3): 583-6.
  14. Tripathi P, Singh V, Naik S. Immune response to leishmania: paradox rather than paradigm. FEMS Immunol Med Microbiol. 2007; 51: 229-42.
  15. Sacks D, Noben-Trauth N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol. 2002; 2: 845-58.
  16. Reiner SL, Locksley RM. The regulation of imunity to Leishmania Mayor. Ann Rev Immunol. 1995; 13: 151-77.
  17. Scott P, Artis D, Uzonna J, Zaph C. The development of effector and memory T cells in cutaneous leishmaniasis: the implications for vaccine development. Immunol Rev. 2004; 201: 318-38.
  18. Launois P, Louis JA, Milon G. The fate and persistence of Leishmania major in mice of different genetic backgrounds: an example of exploitation of the immune system by intracellular parasites. Parasitology. 1997; 115 Suppl: S25-S32.
  19. Lazarski Ch.A., Ford J., Katzman Sh.D. et al. IL-4 attenuates Th1-associated chemokine expression and Th1 trafficking to inflamed tissues and limits pathogen clearance. PloS One. 2013; 8.
  20. Schwarz T., Remet K., Nahrendorf W. et al. T-cell derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine. PLOS Pathog. 2013; 9(56).
  21. Neumayr A.L., Morizot G., Visser L.G. et al. Clinical aspects and management of cutaneous leishmaniasis in rheumatoid patients treated with TNF-α antagonists. Travel Med. Infect. Dis. 2013; 11(6): 412-20.

Copyright (c) 2019 Eco-vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies